May 6, 2020 / 6:19 AM / 21 days ago

BRIEF-Kiadis Pharma Announces FDA Approval To Start NK-REALM Phase 2 Clinical Trial

May 6 (Reuters) - Kiadis Pharma NV:

* KIADIS PHARMA ANNOUNCES U.S. FDA APPROVAL TO START NK-REALM PHASE 2 CLINICAL TRIAL FOR NATURAL KILLER (NK) CELL THERAPY PRODUCED WITH PM21 Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below